Biodexa Pharmaceuticals Plc (BDRX)
USD 1.5
(5.28%)
USD 1.5
(5.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.82 Million | -7.04 Million | -6 Million | -9.3 Million | -6.48 Million | -13.45 Million |
| Net Income | -7.07 Million | -7.65 Million | -5.46 Million | -22.18 Million | -10.08 Million | -15.03 Million |
| Depreciation & Amortization | 283 Thousand | 343 Thousand | 403 Thousand | 1.21 Million | 1.28 Million | 1.11 Million |
| Deferred income taxes | -406 Thousand | -832 Thousand | 469 Thousand | 13.2 Million | -1.78 Million | - |
| Stock-based compensation | 28 Thousand | 123 Thousand | 89 Thousand | -404 Thousand | -34 Thousand | - |
| Change in working capital | -49 Thousand | 520 Thousand | -617 Thousand | -1.55 Million | 1.79 Million | 1.54 Million |
| Other non-cash items | 397 Thousand | 454 Thousand | -892 Thousand | 430 Thousand | 2.33 Million | -1.07 Million |
| Investing Cash Flow | -265 Thousand | -220 Thousand | -278 Thousand | 2.57 Million | -3.8 Million | 9.04 Million |
| Investments in PPE | -263 Thousand | -62 Thousand | -320 Thousand | -209 Thousand | -319 Thousand | -244 Thousand |
| Acquisitions | - | - | - | - | -947 Thousand | - |
| Investment purchases | - | - | - | - | -2.54 Million | - |
| Sales/Maturities of investments | - | - | - | 2.63 Million | - | - |
| Other Investing Activities | -2000.00 | -158 Thousand | 42 Thousand | 144 Thousand | -939 Thousand | 9.28 Million |
| Financing Cash Flow | 10.22 Million | 47 Thousand | 8.8 Million | 3.08 Million | 18.73 Million | -6.47 Million |
| Debt repayment | -188 Thousand | -178 Thousand | -103 Thousand | -6.18 Million | -1.02 Million | -5.88 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.42 Million | 243 Thousand | 9.03 Million | 9.74 Million | 14.1 Million | - |
| Other Financing Activities | 10.41 Million | -18 Thousand | -127 Thousand | -476 Thousand | 5.65 Million | -587 Thousand |
| Accounts receivables | 365 Thousand | 7000.00 | -487 Thousand | 493 Thousand | 725 Thousand | 1.03 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | 347 Thousand |
| Other working capital | -414 Thousand | 513 Thousand | -130 Thousand | -2.05 Million | 1.07 Million | 165 Thousand |
| Cash at beginning of period | 2.83 Million | 10.05 Million | 7.54 Million | 10.92 Million | 2.34 Million | 13.2 Million |
| Cash at end of period | 5.97 Million | 2.83 Million | 10.05 Million | 7.54 Million | 10.92 Million | 2.34 Million |
| Capital Expenditure | -263 Thousand | -62 Thousand | -320 Thousand | -209 Thousand | -319 Thousand | -244 Thousand |
| Effect of forex changes on cash | - | - | -8000.00 | 261 Thousand | 148 Thousand | 19 Thousand |
| Net cash flow / Change in cash | 3.13 Million | -7.22 Million | 2.51 Million | -3.38 Million | 8.58 Million | -10.86 Million |
| Free Cash Flow | -7.08 Million | -7.11 Million | -6.32 Million | -9.51 Million | -6.8 Million | -13.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.65 Million | -1.65 Million | -1.75 Million | -7.07 Million | -1.75 Million | -1.78 Million |
| Depreciation & Amortization | 68 Thousand | 68 Thousand | 70 Thousand | 283 Thousand | 70 Thousand | 71.5 Thousand |
| Deferred income taxes | - | - | - | -406 Thousand | - | -59 Thousand |
| Stock-based compensation | 75 Thousand | 75 Thousand | 6500.00 | 28 Thousand | 6500.00 | 7500.00 |
| Change in working capital | -649 Thousand | -649 Thousand | 131 Thousand | -49 Thousand | 131 Thousand | -52 Thousand |
| Other non-cash items | -243.5 Thousand | -243.5 Thousand | 75.5 Thousand | 397 Thousand | 75.5 Thousand | -183.5 Thousand |
| Investing Cash Flow | -377 Thousand | -377 Thousand | -142.5 Thousand | -265 Thousand | -142.5 Thousand | 10 Thousand |
| Investments in PPE | - | - | -11 Thousand | -263 Thousand | -11 Thousand | -2000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -377 Thousand | -377 Thousand | -131.5 Thousand | -2000.00 | -131.5 Thousand | 12 Thousand |
| Financing Cash Flow | 2.32 Million | 2.32 Million | 1.98 Million | 10.22 Million | 1.98 Million | 3.12 Million |
| Debt repayment | - | - | - | -188 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 10.42 Million | - | - |
| Other Financing Activities | 2.32 Million | 2.32 Million | 1.98 Million | 10.41 Million | 1.98 Million | 3.12 Million |
| Accounts receivables | -649 Thousand | -649 Thousand | 131 Thousand | 365 Thousand | 131 Thousand | 51.5 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -414 Thousand | - | -103.5 Thousand |
| Cash at beginning of period | - | - | - | 2.83 Million | - | - |
| Cash at end of period | -458 Thousand | -458 Thousand | 372 Thousand | 5.97 Million | 372 Thousand | 1.19 Million |
| Capital Expenditure | - | - | -11 Thousand | -263 Thousand | -11 Thousand | -2000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -458 Thousand | -458 Thousand | 372 Thousand | 3.13 Million | 372 Thousand | 1.19 Million |
| Free Cash Flow | -2.4 Million | -2.4 Million | -1.48 Million | -7.08 Million | -1.48 Million | -1.94 Million |
CBIT
SBKFF
TPB
MOV
CULL
HLTRF